A Functional Yeast Survival Screen of Tumor-Derived cDNA Libraries Designed to Identify Anti-Apoptotic Mammalian Oncogenes

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Eißmann, Moritz ^a   Schwamb, Bettina ^a   Melzer, Inga Maria ^a   Moser, Julia ^a   Siele, Dagmar ^a,h   Köhl, Ulrike ^b   Rieker, Ralf Joachim ^c   Wachter, David Lukas ^c   Agaimy, Abbas ^c   Herpel, Esther ^d   Baumgarten, Peter ^e   Mittelbronn, Michel ^e   Rakel, Stefanie ^f   Kögel, Donat ^f   Böhm, Stefanie ^a,i   Gutschner, Tony ^g   Diederichs, Sven ^g   Zörnig, Martin ^a  

^a INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e Institute of Neurology (Edinger Institute)   (Germany)

^f UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^g GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^h BIACORE AB   (Sweden)

ⁱ UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INHIBITOR; COMPLEMENTARY DNA; ENZYME; METASTASIS ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1 PROTEIN; MICROTUBULE ASSOCIATED PROTEIN SERINE THREONINE KINASE 2; PHOSPHORIBOSYLAMINOIMIDAZOLE SUCCINOCARBOXAMIDE SYNTHETASE; PHOSPHOTRANSFERASE; PURINE; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ACUTE LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DNA DETERMINATION; DNA LIBRARY; DNA SCREENING; ENZYME ACTIVITY; GENE ACTIVITY; GENE FUNCTION; GENE IDENTIFICATION; GENE INDUCTION; GENE ISOLATION; GENE OVEREXPRESSION; GENE TARGETING; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALAT1 GENE; MALIGNANT NEOPLASTIC DISEASE; MAMMAL; MAST2 GENE; METASTATIC MELANOMA; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; ONCOGENE; PAICS GENE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PURINE SYNTHESIS; SURVIVAL PREDICTION; TUMOR GROWTH; TUMOR XENOGRAFT; YEAST; YEAST CELL;

APOPTOSIS; BASE SEQUENCE; BLOTTING, WESTERN; DNA PRIMERS; DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; HEK293 CELLS; HUMANS; NEOPLASMS; ONCOGENES; REAL-TIME POLYMERASE CHAIN REACTION; SCHIZOSACCHAROMYCES;

EID: 84878080320     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064873     Document Type: Article

References (75)

1. Nagata S, Hanayama R, Kawane K, (2010) Autoimmunity and the clearance of dead cells. Cell 140: 619-630.
2. Zörnig M, Hueber A, Baum W, Evan G, (2001) Apoptosis regulators and their role in tumorigenesis. Biochim Biophys Acta 1551: F1-37.
3. Wiezorek J, Holland P, Graves J, (2010) Death receptor agonists as a targeted therapy for cancer. Clin Cancer Res 16: 1701-1708.
4. Gupta S, Kass GE, Szegezdi E, Joseph B, (2009) The mitochondrial death pathway: a promising therapeutic target in diseases. J Cell Mol Med 13: 1004-1033.
5. Strasser A, Cory S, Adams JM, (2011) Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. EMBO J 30: 3667-3683.
6. Hotchkiss RS, Strasser A, McDunn JE, Swanson PE, (2009) Cell death. N Engl J Med 361: 1570-1583.
7. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
8. Long JS, Ryan KM (2012) New frontiers in promoting tumour cell death: targeting apoptosis, necroptosis and autophagy. Oncogene.
9. Taddei ML, Giannoni E, Fiaschi T, Chiarugi P, (2012) Anoikis: an emerging hallmark in health and diseases. J Pathol 226: 380-393.
10. Wilson WR, Hay MP, (2011) Targeting hypoxia in cancer therapy. Nat Rev Cancer 11: 393-410.
11. Chen G, Shu J, Stacey DW, (1997) Oncogenic transformation potentiates apoptosis, S-phase arrest and stress-kinase activation by etoposide. Oncogene 15: 1643-1651.
12. Sodir NM, Evan GI, (2011) Finding cancer's weakest link. Oncotarget 2: 1307-1313.
13. Bohl SR, Pircher A, Hilbe W, (2011) Cancer stem cells: characteristics and their potential role for new therapeutic strategies. Onkologie 34: 269-274.
14. Yu Y, Ramena G, Elble RC, (2012) The role of cancer stem cells in relapse of solid tumors. Front Biosci (Elite Ed) 4: 1528-1541.
15. Ink B, Zornig M, Baum B, Hajibagheri N, James C, et al. (1997) Human Bak induces cell death in Schizosaccharomyces pombe with morphological changes similar to those with apoptosis in mammalian cells. Mol Cell Biol 17: 2468-2474.
16. James C, Gschmeissner S, Fraser A, Evan GI, (1997) CED-4 induces chromatin condensation in Schizosaccharomyces pombe and is inhibited by direct physical association with CED-9. Curr Biol 7: 246-252.
17. Jurgensmeier JM, Krajewski S, Armstrong RC, Wilson GM, Oltersdorf T, et al. (1997) Bax- and Bak-induced cell death in the fission yeast Schizosaccharomyces pombe. Mol Biol Cell 8: 325-339.
18. Greenhalf W, Lee J, Chaudhuri B, (1999) A selection system for human apoptosis inhibitors using yeast. Yeast 15: 1307-1321.
19. Matsuyama S, Xu Q, Velours J, Reed JC, (1998) The Mitochondrial F0F1-ATPase proton pump is required for function of the proapoptotic protein Bax in yeast and mammalian cells. Mol Cell 1: 327-336.
20. Xu Q, Reed JC, (1998) Bax inhibitor-1, a mammalian apoptosis suppressor identified by functional screening in yeast. Mol Cell 1: 337-346.
21. Brezniceanu ML, Volp K, Bosser S, Solbach C, Lichter P, et al. (2003) HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma. FASEB J 17: 1295-1297.
22. Gorelik E, Lokshin A, Levina V, (2010) Lung cancer stem cells as a target for therapy. Anticancer Agents Med Chem 10: 164-171.
23. Haar CP, Hebbar P, Wallace GCt, Das A, Vandergrift WA3rd,et al. (2012) Drug Resistance in Glioblastoma: A Mini Review. Neurochem Res.
24. Ulukaya E, Acilan C, Yilmaz Y, (2011) Apoptosis: why and how does it occur in biology? Cell Biochem Funct 29: 468-480.
25. Zakeri Z, Lockshin RA, (2002) Cell death during development. J Immunol Methods 265: 3-20.
26. Tischner D, Woess C, Ottina E, Villunger A, (2010) Bcl-2-regulated cell death signalling in the prevention of autoimmunity. Cell Death Dis 1: e48.
27. Moreno S, Klar A, Nurse P, (1991) Molecular genetic analysis of fission yeast Schizosaccharomyces pombe. Methods Enzymol 194: 795-823.
28. Maundrell K, (1990) nmt1 of fission yeast. A highly transcribed gene completely repressed by thiamine. J Biol Chem 265: 10857-10864.
29. Maundrell K, (1993) Thiamine-repressible expression vectors pREP and pRIP for fission yeast. Gene 123: 127-130.
30. Gutschner T, Baas M, Diederichs S, (2011) Noncoding RNA gene silencing through genomic integration of RNA destabilizing elements using zinc finger nucleases. Genome Res 21: 1944-1954.
31. Wellenreuther R, Schupp I, Poustka A, Wiemann S, (2004) SMART amplification combined with cDNA size fractionation in order to obtain large full-length clones. BMC Genomics 5: 36.
32. Kucsera J, Yarita K, Takeo K, (2000) Simple detection method for distinguishing dead and living yeast colonies. J Microbiol Methods 41: 19-21.
33. Buh Gasparic M, Tengs T, La Paz JL, Holst-Jensen A, Pla M, et al. (2010) Comparison of nine different real-time PCR chemistries for qualitative and quantitative applications in GMO detection. Anal Bioanal Chem 396: 2023-2029.
34. Schefe JH, Lehmann KE, Buschmann IR, Unger T, Funke-Kaiser H, (2006) Quantitative real-time RT-PCR data analysis: current concepts and the novel "gene expression's CT difference" formula. J Mol Med (Berl) 84: 901-910.
35. Pourkarimi E, Greiss S, Gartner A, (2012) Evidence that CED-9/Bcl2 and CED-4/Apaf-1 localization is not consistent with the current model for C. elegans apoptosis induction. Cell Death Differ 19: 406-415.
36. Riccardi C, Nicoletti I, (2006) Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc 1: 1458-1461.
37. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X, (1997) Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90: 405-413.
38. Melzer IM, Fernandez SB, Bosser S, Lohrig K, Lewandrowski U, et al. (2012) The Apaf-1-binding protein Aven is cleaved by Cathepsin D to unleash its anti-apoptotic potential. Cell Death Differ 19: 1435-1445.
39. Chinnaiyan AM, O'Rourke K, Lane BR, Dixit VM, (1997) Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science 275: 1122-1126.
40. Ewan KB, Dale TC, (2008) The potential for targeting oncogenic WNT/beta-catenin signaling in therapy. Curr Drug Targets 9: 532-547.
41. Yao H, Ashihara E, Maekawa T, (2011) Targeting the Wnt/beta-catenin signaling pathway in human cancers. Expert Opin Ther Targets 15: 873-887.
42. Johnston NI, Gunasekharan VK, Ravindranath A, O'Connell C, Johnston PG, et al. (2008) Osteopontin as a target for cancer therapy. Front Biosci 13: 4361-4372.
43. Cao L, Bombard J, Cintron K, Sheedy J, Weetall ML, et al. (2011) BMI1 as a novel target for drug discovery in cancer. J Cell Biochem 112: 2729-2741.
44. Nonn L, Berggren M, Powis G, (2003) Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis. Mol Cancer Res 1: 682-689.
45. Ayala GE, Dai H, Ittmann M, Li R, Powell M, et al. (2004) Growth and survival mechanisms associated with perineural invasion in prostate cancer. Cancer Res 64: 6082-6090.
46. Soler DC, Kadunganattil S, Ramdas S, Myers K, Roca J, et al. (2009) Expression of transgenic PPP1CC2 in the testis of Ppp1cc-null mice rescues spermatid viability and spermiation but does not restore normal sperm tail ultrastructure, sperm motility, or fertility. Biol Reprod 81: 343-352.
47. Sun W, Zhang K, Zhang X, Lei W, Xiao T, et al. (2004) Identification of differentially expressed genes in human lung squamous cell carcinoma using suppression subtractive hybridization. Cancer Lett 212: 83-93.
48. Alves PM, Faure O, Graff-Dubois S, Cornet S, Bolonakis I, et al. (2006) STEAP, a prostate tumor antigen, is a target of human CD8+ T cells. Cancer Immunol Immunother 55: 1515-1523.
49. Grunewald TG, Diebold I, Esposito I, Plehm S, Hauer K, et al. (2012) STEAP1 Is Associated with the Invasive and Oxidative Stress Phenotype of Ewing Tumors. Mol Cancer Res 10: 52-65.
50. Maia CJ, Socorro S, Schmitt F, Santos CR, (2008) STEAP1 is over-expressed in breast cancer and down-regulated by 17beta-estradiol in MCF-7 cells and in the rat mammary gland. Endocrine 34: 108-116.
51. Gutschner T, Diederichs S (2012) The Hallmarks of Cancer: A long non-coding RNA point of view. RNA Biol 9: in press.
52. Ji P, Diederichs S, Wang W, Boing S, Metzger R, et al. (2003) MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22: 8031-8041.
53. Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY,et al. (2011) Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol.
54. Valiente M, Andres-Pons A, Gomar B, Torres J, Gil A, et al. (2005) Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases. J Biol Chem 280: 28936-28943.
55. Xiong H, Li H, Chen Y, Zhao J, Unkeless JC, (2004) Interaction of TRAF6 with MAST205 regulates NF-kappaB activation and MAST205 stability. J Biol Chem 279: 43675-43683.
56. Zhou H, Xiong H, Li H, Plevy SE, Walden PD, et al. (2004) Microtubule-associated serine/threonine kinase-205 kDa and Fc gamma receptor control IL-12 p40 synthesis and NF-kappa B activation. J Immunol 172: 2559-2568.
57. Ito R, Sekiguchi M, Setoyama D, Nakatsu Y, Yamagata Y, et al. (2011) Cleavage of oxidized guanine nucleotide and ADP sugar by human NUDT5 protein. J Biochem 149: 731-738.
58. Zhang LQ, Dai DP, Gan W, Takagi Y, Hayakawa H,et al. (2011) Lowered Nudix type 5 (NUDT5) expression leads to cell cycle retardation in HeLa cells. Mol Cell Biochem.
59. Li SX, Tong YP, Xie XC, Wang QH, Zhou HN, et al. (2007) Octameric structure of the human bifunctional enzyme PAICS in purine biosynthesis. J Mol Biol 366: 1603-1614.
60. McGuire JJ, (2003) Anticancer antifolates: current status and future directions. Curr Pharm Des 9: 2593-2613.
61. Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, et al. (2010) The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell 39: 925-938.
62. Schmidt LH, Spieker T, Koschmieder S, Humberg J, Jungen D, et al. (2011) The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. J Thorac Oncol 6: 1984-1992.
63. Walden PD, Cowan NJ, (1993) A novel 205-kilodalton testis-specific serine/threonine protein kinase associated with microtubules of the spermatid manchette. Mol Cell Biol 13: 7625-7635.
64. Garland P, Quraishe S, French P, O'Connor V, (2008) Expression of the MAST family of serine/threonine kinases. Brain Res 1195: 12-19.
65. Unterkircher T, Cristofanon S, Vellanki SH, Nonnenmacher L, Karpel-Massler G, et al. (2011) Bortezomib primes glioblastoma, including glioblastoma stem cells, for TRAIL by increasing tBid stability and mitochondrial apoptosis. Clin Cancer Res 17: 4019-4030.
66. Westhouse RA, (2010) Safety assessment considerations and strategies for targeted small molecule cancer therapeutics in drug discovery. Toxicol Pathol 38: 165-168.
67. Yauch RL, Settleman J (2012) Recent advances in pathway-targeted cancer drug therapies emerging from cancer genome analysis. Curr Opin Genet Dev.
68. Speirs CK, Hwang M, Kim S, Li W, Chang S, et al. (2011) Harnessing the cell death pathway for targeted cancer treatment. Am J Cancer Res 1: 43-61.
69. Luo JH, Ren B, Keryanov S, Tseng GC, Rao UN, et al. (2006) Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology 44: 1012-1024.
70. Lin R, Maeda S, Liu C, Karin M, Edgington TS, (2007) A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene 26: 851-858.
71. Guffanti A, Iacono M, Pelucchi P, Kim N, Solda G, et al. (2009) A transcriptional sketch of a primary human breast cancer by 454 deep sequencing. BMC Genomics 10: 163.
72. Yamada K, Kano J, Tsunoda H, Yoshikawa H, Okubo C, et al. (2006) Phenotypic characterization of endometrial stromal sarcoma of the uterus. Cancer Sci 97: 106-112.
73. Xu C, Yang M, Tian J, Wang X, Li Z, (2011) MALAT-1: a long non-coding RNA and its important 3′ end functional motif in colorectal cancer metastasis. Int J Oncol 39: 169-175.
74. Robinson DR, Kalyana-Sundaram S, Wu YM, Shankar S, Cao X, et al. (2011) Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer. Nat Med 17: 1646-1651.
75. Gutschner T, Hammerle M, Eissmann M, Hsu J, Kim Y, et al. (2013) The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 73: 1180-1189.